Swiss pharma Roche is staying in…
Swiss pharma Roche is staying in lockstep with Eli Lilly, [...]
Swiss pharma Roche is staying in lockstep with Eli Lilly, [...]
While BioMarin has been focusing heavily on its CNP analogue, [...]
Amgen’s Amjevita, Aimovig and Repatha—plus GSK’s Ellipta inhalers and its [...]
Idorsia is gearing up for another CEO change with the [...]
Astellas is pulling out of its $1.6 billion biobucks partnership [...]
Structure Therapeutics has touted the 16% weight loss seen by [...]
Fármacos como Wegovy y Zepbound han sido aclamados como tratamientos [...]
The CEO’s 2025 pay was a sizeable bump over the [...]
In a 14-month follow-up, Sana Biotechnology has found that its [...]
GSK has secured an FDA expansion for its respiratory syncytial [...]